According to the academy, intraocular lenses function in different ways to address a range of vision issues. Bausch + Lomb issued the recall after it received reports of toxic anterior segment ...

The FDA elevated a recall of intraocular lenses currently being wrapped up by Bausch + Lomb, following increased reports of ...

This retrospective case series involved a review of medical records at a single tertiary care center. Charbel Issa and ...

The company recalled the lenses in March after receiving reports of toxic anterior segment syndrome (TASS) among patients implanted with the IOLs in the U.S. Bausch + Lomb will return its enVista ...

Mild intraocular inflammation occurred more frequently after intravitreal aflibercept (8 mg) injections in real-world practice than reported in clinical trials, with an incidence of 3.7% per ...

Bausch + Lomb has recalled its intraocular lenses after receiving ... in response to an increased number of reports of toxic anterior segment syndrome in conjunction with implantation of enVista ...

Aqueous humor is produced by the pigmented and nonpigmented epithelia of the ciliary processes of the ciliary body in the ocular anterior segment ... Control of Acular Inflammation Nonsteroidal ...

Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of ... diminution in edema and inflammation.

Although the patient was treated with dexamethasone drops eight times daily and with mydriatic agents, active anterior uveitis persisted, with spill-over inflammation to the posterior segment of ...

In addition to its pipeline, VivaVision is actively engaged in the discovery and development of additional therapies for anterior and posterior segment eye diseases to address unmet patient needs. For ...

The analysis included 41 patients who were treated with 136 intravitreal aflibercept, 8mg, injections. HealthDay News — The incidence of mild intraocular inflammation (IOI) in the real world ...